{"id":"W2097463411","doi":"10.1016/j.lungcan.2012.05.111","title":"A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma","year":2012,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Pemetrexed; Bevacizumab; Clinical endpoint; Internal medicine; Mesothelioma; Neutropenia; Progression-free survival; Oncology; Vascular endothelial growth factor; Gastroenterology; Cisplatin; Phases of clinical research; Survival rate; Chemotherapy; Surgery; Pathology; Clinical trial; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002194116,0.001327317,0.002860877,0.0004525779,0.0005452943,0.001171846,0.0009302133,0.001062807,0.002212751],"category_scores_gemma":[0.001554834,0.0008573405,0.001832952,0.0005593587,0.001111682,0.001509523,0.0004907397,0.003551245,0.0004989844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001233306,"about_ca_system_score_gemma":0.001650268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001436106,"about_ca_topic_score_gemma":0.002914898,"domain_scores_codex":[0.9992229,0.0004189532,0.00004317375,0.0001461863,0.00005616068,0.0001127677],"domain_scores_gemma":[0.9989095,0.000203856,0.0001929567,0.0001122061,0.00007367336,0.0005078083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8841546,0.03243285,0.009328959,0.0004386637,0.00210787,0.0001219243,0.0002571506,0.001670331,0.01674451,0.0001617791,0.001619457,0.05096199],"study_design_scores_gemma":[0.727581,0.2540012,0.01373537,0.00002148882,0.0009184165,0.0001351587,0.00007997789,0.0007559077,0.001176977,0.0001241153,0.001442994,0.00002743421],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959603,0.001678855,0.0002767603,0.0003408817,0.00009902992,0.0007921612,0.0003070097,0.00002835548,0.0005167379],"genre_scores_gemma":[0.9947624,0.001250095,0.0008872656,0.0004547558,0.0001496343,0.0009101212,0.0008060537,0.00001875008,0.000760997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002860877,"threshold_uncertainty_score":0.01160377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006440750221946768,"score_gpt":0.2942190817725004,"score_spread":0.2877783315505536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}